FdaApplication

ANDA 211593

Back to search

Identifiers

Properties

PropertyValue
applicant_nameALVOGEN INC
application_typeANDA
approval_date2021-04-13

Products (3)

ProductActive ingredientStrengthDosage form
PREGABALINPREGABALIN165MGTABLET, EXTENDED RELEASE;ORAL
PREGABALINPREGABALIN82.5MGTABLET, EXTENDED RELEASE;ORAL
PREGABALINPREGABALIN330MGTABLET, EXTENDED RELEASE;ORAL

3 products